Validity of International Normalized Ratio in Expressing Prothrombin Times in Anticoagulated and Nonanticoagulated Patients

Abstract

We investigated the effect of four thrombo plastins with different International Sensitivity Index (ISI) values on prothrombin times (PTs), expressed as International Normalized Ratios (INRs), of 30 normal plasmas, 30 patients on stable oral anticoagulant (OA) therapy, and 30 patients with prolonged PTs for reasons other than OA therapy. Normal ranges became signifi cantly longer when three thromboplastins of rabbit brain origin were used—the lower the ISI, the wider the normal range. The human placenta-derived thromboplastin had a range similar to the values obtained with the most insen sitive rabbit reagent. Significantly different INR values were noted when normal plasmas and plasmas of patients with prolonged PTs not due to OA therapy were tested. This was not the case when specimens from patients on OAs were tested. When PT values from 212 consecutive ly selected patients were tested with the least sensitive rabbit reagent (ISI 2.477) and the most sensitive human placenta reagent (ISI 1.06), significantly more "abnor mal" PTs were identified with the high-sensitivity throm boplastin. The data indicate that special attention has to be paid to "normal" ranges when thromboplastins with low ISI replace less sensitive reagents, that INR should not be used to express PT in patients not on stable OA therapy, and that with the routine use of highly sensitive reagents (low ISI) more abnormal patients are identified.

Keywords

Prothrombin times International normalized ratio International sensitivity index Oral anticoagulants Thromboplastin.

Get full access to this article

View all access options for this article.

References

Quick AJ , Stanley-Brown M. , Bancroft FW A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 1935;190:501.

Swaim WR Prothrombin time reporting and the International Normalized Ratio system: improvements are needed [Editorial]. Am J Clin Pathol 1993 ;99:653.

Hirsh J. , Poller L. The International Normalized Ratio: a guide to understanding and correcting its problems. Arch Intern Med 1994;154:282.

Kitchen S. , Walker ID , Woods Tal , Preston FE Thromboplastin related differences in the determination of International Normalized Ratio: a cause for concern? Thromb Haemostas 1994;72:426.

Poller L. The effect of the use of different tissue extracts on one-stage prothrombin times. Acta Haematol 1964;32:292. 6. Hirsh J. Substandard monitoring of warfarin in North America: time for change [Editorial] . Arch Intern Med 1992;152: 25.

Bussey HI , Force RW , Bianco TM , Leonard AD Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy. Arch Intern Med 1992;152:278.

Ansell JE Oral anticoagulant therapy: 50 years later. Arch Intern Med 1993;153:586.

WHO Expert Committee on Biological Standardization. Thirty-third report. WHO Technical Report Series 1983;687: 81.

Kirkwood Tbl. Calibration of reference thromboplastins and standardization of the prothrombin time ratio. Thromb Haemostas 1983;49:238.

10.

Van den Besselaar Amhp.

Monitoring oral anticoagulant therapy by the prothrombin time: reporting the coagulation activity or the International Normalized

Ratio. Haemostasis 1994 ;24: 1.

11.

Kovacs MJ , Wong A. , Mackinnon K. , et al. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemostas 1994 ;71:727.

12.

McKernan A. , Thomson JM , Poller L. The reliability of International Normalized Ratios during short-term oral anticoagulant therapy. Clin Lab Haemostas 1988;10:63.

13.

Ts'ao C. , Neofotistos D. The use and limitations of the INR system. Am J Hematol 1994 ;47:21.

14.

Poller L. , Taberner DA , Thompson JM , Darby KV Survey of prothrombin time in national external quality assessment scheme exercises (1980-1987). J Clin Pathol 1988;41:361.

15.

Taberner DA , Poller L. , Thompson JM , Darby KV The effect of International Sensitivity Index (ISI) of thromboplastins on precision of International Normalized Ratio (INR) . J Clin Pathol 1989;42:92.

16.

Ts'ao C. , Swedlund J. , Neofotistos D. Implications of use of low International Sensitivity Index thromboplastins in prothrombin time testing. Arch Pathol Lab Med 1994;118:1183.

17.

Barrow OA Safer therapies through improved diagnostics: how highly responsive coagulation reagents and the Behring Fibrintimer A (BFA) improve patient monitoring . West-wood, MA: Behring Diagnostic, Inc., 1994.

18.

Koepke JA Is the International Normalized Ratio also "valid" for prothrombin times measured in patients not receiving oral anticoagulant? [Editorial]. Arch Pathol Lab Med 1994;118:1181.